Independent Ledger Beresford operates as a ledger fund with no external assets under management, no carry, and limited outside investors. This highlights a potential sales angle around value-aligned, low-pressure investment opportunities and bespoke co-investment arrangements for strategic partners or family offices seeking aligned interests.

Early Stage Focus The firm is sector agnostic and primarily writes small pre-seed checks. This suggests opportunities to engage with early-stage startups across industries, offering tailored capital solutions, hands-on support, and value-add services that align with their founder-friendly, decentralized investment approach.

Global Portfolio With 135 companies backed across the US, Canada, Latin America, the Middle East, and Africa, Beresford presents a diversified international network. This creates sales opportunities for portfolio-wide services such as cross-border fundraising, regulatory guidance, market entry support, and introductions to potential co-investors or strategic customers.

Recent Investment Recent funding activity includes a $2M seed investment in Hyivy Health Inc. This demonstrates ongoing deal flow and openness to healthcare tech opportunities, suggesting a potential focus area for partnerships, distribution, or enterprise-ready tech integrations within the health tech ecosystem.

Private Fund Narrative As a private, self-funded group investing their own capital with a ledger approach, Beresford may be receptive to high-trust, bespoke collaboration models, such as co-investment syndicates, strategic alliances, or advisory services for fintech, proptech, or deeptech startups seeking patient capital and flexible governance.